Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA.
$SRNE Sorrento’s – new – RESPI-STIX – Will be able to tell you if you have the FLU, Covid or both. “Medical diagnostic test kits for the clinical detection of Influenza A, Influenza B, Covid-19 and Coronavirus featuring lateral flow tests; Influenza A, Influenza B, COVID-19 and Coronavirus lateral flow viral antigen diagnostic test” RESPI-STIX Trademark link: uspto.report/TM/https://uspto.report/TM/9046211690462116
